Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 19.91
+0.44 (2.26%)
At close: Mar 18, 2026
Frontier Biotechnologies Market Cap
Frontier Biotechnologies has a market cap or net worth of 7.46 billion as of March 19, 2026. Its market cap has increased by 96.35% in one year.
Market Cap
7.46B
Enterprise Value
7.14B
Revenue
143.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.91
Market Cap Chart
Since October 28, 2020, Frontier Biotechnologies's market cap has decreased from 10.76B to 7.46B, a decrease of -30.69%. That is a compound annual growth rate of -6.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 7.46B | 10.30% |
| Dec 31, 2025 | 6.76B | 84.94% |
| Dec 31, 2024 | 3.66B | -1.61% |
| Dec 29, 2023 | 3.72B | -42.53% |
| Dec 30, 2022 | 6.47B | -3.33% |
| Dec 31, 2021 | 6.69B | -3.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northeast Pharmaceutical Group | 7.62B |
| Cisen Pharmaceutical | 7.62B |
| Sichuan Huiyu Pharmaceutical | 7.57B |
| Dezhan Healthcare Company | 7.53B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 7.48B |
| Sunflower Pharmaceutical Group Co.,Ltd | 7.33B |
| Hainan Haiyao | 7.29B |
| Hunan Jiudian Pharmaceutical | 7.28B |